Rafael Holdings stockholders approve share issuance for Cyclo Therapeutics merger

Rafael Holdings, Inc.

Share issuance proposal passed with 3,706,261 votes For (99.92%) vs. 1,571 Against.
Adjournment proposal also approved with 3,676,323 For (99.77%) and 32,783 Against.
Special meeting held March 20, 2025; both proposals were stockholder votes required to proceed with merger.
Transaction involves exchange of Rafael Class B common stock for Cyclo common stock under August 2024 merger agreement.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.